Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial

Table 3

Changes from baseline to the end of the study on clinical laboratory tests.

Variable	Period	SJDBT group		Placebo group
		Mean ± SD		Mean ± SD
ACTH	0 weeks					0.771
	4 weeks		0.468		0.199	0.963
	Δ(0–)					0.683
Cortisol	0 weeks					0.995
	4 weeks		0.982		0.316	0.350
	Δ(0–)					0.441
Ghrelin	0 weeks					0.526
	4 weeks		0.036		0.044	0.992
	Δ(0–)					0.302
IL-6	0 weeks					0.883
	4 weeks		0.213		0.412	0.996
	Δ(0–)					0.934
ESR	0 weeks					0.717
	4 weeks		0.572		0.972	0.539
	Δ(0–)					0.701
CRP	0 weeks					0.983
	4 weeks		0.741		0.570	0.907
	Δ(0–)					0.921

ACTH: adrenocorticotropic hormone; IL-6: interleukin 6; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; represents value of comparison between 0 weeks and 4 weeks within each group; represents value of comparison between SJDBT group and placebo group in each period.